UNSPSC 51352305: Methestrol

This classification denotes a therapeutic estrogen with the molecular formula C20H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 199O25Z2BQ, chemically known as 4,4-(1,2-diethylethylene)di-o-cresol but generally known as methestrol, which bears US NIH Compound Identifier 71620. European Medicines Agency schedules Methestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08847MIG. The term METHESTROL is an International Non-Proprietary Name.

UNSPSC 51352305 Methestrol, a Commodity code, encompasses pharmaceutical products being solicited by state and local cooperative purchasing alliances and health systems for distribution to government facilities and participating jurisdictions. The scope under this code includes generic and branded pharmaceutical products supplied through established wholesale distribution networks, with vendors required to provide comprehensive product specifications including National Drug Codes, packaging configurations, dosage forms, and manufacturing locations. Solicitations demand compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, established relationships with authorized wholesalers maintaining chargeback systems, and flexible pricing structures such as flat price, net price formats, or WAC-minus pricing. The issuing bodies include state departments of administration and multistate cooperative purchasing alliances that coordinate procurement across multiple state and local government entities, including health departments, institutional facilities, and participating county and municipal systems.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted a Request for Proposal on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products serving Minnesota, Oregon, and other participating jurisdictions. Proposals were due March 26, 2026, with awarded vendors required to make products available by May 15, 2026 and agreements effective July 1, 2026. Evaluation criteria weighted price competitiveness at 75 percent, fixed pricing and compliance with administrative requirements at 10 and 5 percent respectively, EDI capability and administrative fee agreement at 5 percent each. Vendors must maintain commercial general liability coverage of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000, with contract terms of two years for new vendors and optional MMCAP-discretionary extensions.